The clinical effectiveness of PSMA PET-CT-only defined and escalated treatment compared to conventional imaging for high-risk prostate cancer: a double-blind, multicentre, randomised controlled trial (IP10-AVIDITY)

The clinical effectiveness of PSMA PET-CT-only defined and escalated treatment compared to conventional imaging for high-risk prostate cancer: a double-blind, multicentre, randomised controlled trial (IP10-AVIDITY)

Sunday, May 17, 2026 2:20 PM to 2:28 PM · 8 min. (America/New_York)
Hall B, The Square, Learning Lab
Detail
Oncology: Prostate

Log in

See all the content and easy-to-use features by logging in or registering!